Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 13,150 | 13,436 | 11,475 | 12,625 | 14,191 |
| Operating Income | -13,150 | -13,436 | -11,475 | -12,625 | -14,191 |
| Interest Expense | 352 | 269 | 257 | 250 | 160 |
| Other Income | -962 | 300 | -465 | -229 | -105 |
| Pre-tax Income | -14,463 | -13,404 | -12,197 | -13,105 | -14,456 |
| Income Tax | N/A | N/A | N/A | 2 | N/A |
| Net Income Continuous | -14,463 | -13,404 | -12,197 | -13,107 | -14,456 |
| Net Income | $-14,463 | $-13,404 | $-12,197 | $-13,107 | $-14,456 |
| EPS Basic Total Ops | -1.60 | -1.40 | -1.40 | -1.80 | -2.40 |
| EPS Basic Continuous Ops | -1.54 | -1.40 | -1.45 | -1.74 | -2.37 |
| EPS Diluted Total Ops | -1.60 | -1.40 | -1.40 | -1.80 | -2.40 |
| EPS Diluted Continuous Ops | -1.54 | -1.40 | -1.45 | -1.74 | -2.37 |
| EBITDA(a) | $-13,099 | $-13,385 | $-11,427 | $-12,543 | $-14,110 |